Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4411

1.

Recent emergence of E. coli carrying blaCTX-M encoded cephalosporin resistance on Washington State dairy farms.

Davis MA, Sischo WM, Jones LP, Moore DA, Ahmed S, Short DM, Besser TE.

Appl Environ Microbiol. 2015 Apr 24. pii: AEM.00463-15. [Epub ahead of print]

PMID:
25911480
2.

Synthesis, biological and electrochemical evaluation of novel nitroaromatics as potential anticancerous drugs.

Shabbir M, Akhter Z, Ahmad I, Ahmed S, Ismail H, Mirza B, Mckee V, Bolte M.

Bioelectrochemistry. 2015 Mar 31;104:85-92. doi: 10.1016/j.bioelechem.2015.03.007. [Epub ahead of print]

PMID:
25911402
3.

The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?

Hartung DM, Bourdette DN, Ahmed SM, Whitham RH.

Neurology. 2015 Apr 24. pii: 10.1212/WNL.0000000000001608. [Epub ahead of print]

PMID:
25911108
4.

Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014.

Ahmed S, Bathe O, Berry S, Buie D, Davies J, Doll C, Dowden S, Gill S, Gordon V, Hebbard P, Jones E, Kennecke H, Koski S, Krahn M, Le D, Lim H, Lund C, Luo Y, Mcffadden A, Mcghie J, Mulder K, Park J, Rashidi F, Sami A, Tan KT, Wong R.

Curr Oncol. 2015 Apr;22(2):e113-23. doi: 10.3747/co.22.2362.

PMID:
25908916
5.

Stakeholder surveys of canadian healthcare performance: what are they telling us? Who should be listening? Who should be acting, and how?

Nemis-White J, Torr E, Gogovor A, Marshall L, Ahmed S, Aylen J, Montague T.

Healthc Q. 2014;17(4):22-7.

PMID:
25906461
6.

Can physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial: study protocol.

Gokal K, Munir F, Wallis D, Ahmed S, Boiangiu I, Kancherla K.

BMC Public Health. 2015 Apr 23;15(1):414. [Epub ahead of print]

PMID:
25903195
7.

Vitamin D, the autonomic nervous system, and cardiovascular risk.

Mann MC, Hollenberg MD, Hanley DA, Ahmed SB.

Physiol Rep. 2015 Apr;3(4). pii: e12349. doi: 10.14814/phy2.12349. No abstract available.

PMID:
25902783
8.

Experimental and Computational Mechanistic Investigation of Chlorocarbene Additions to Bridgehead Carbene-anti-Bredt Systems: Noradamantylcarbene-Adamantene and Adamantylcarbene-Homoadamantene.

Hare SR, Orman M, Dewan F, Dalchand E, Buzard C, Ahmed S, Tolentino JC, Sethi U, Terlizzi K, Houferak C, Stein AM, Stedronsky A, Thamattoor DM, Tantillo DJ, Merrer DC.

J Org Chem. 2015 Apr 22. [Epub ahead of print]

PMID:
25902301
9.

Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C.

Murray C, Griffin ÉW, O'Loughlin E, Lyons A, Sherwin E, Ahmed S, Stevenson NJ, Harkin A, Cunningham C.

Brain Behav Immun. 2015 Apr 18. pii: S0889-1591(15)00114-2. doi: 10.1016/j.bbi.2015.04.009. [Epub ahead of print]

PMID:
25900439
10.

Chikungunya virus outbreak, dominica, 2014.

Ahmed S, Francis L, Ricketts RP, Christian T, Polson-Edwards K, Olowokure B.

Emerg Infect Dis. 2015 May;21(5):909-11. doi: 10.3201/eid2105.141813. No abstract available.

11.

Vitamin D3 supplementation and body composition in persons with obesity and type 2 diabetes in the UAE: A randomized controlled double-blinded clinical trial.

Sadiya A, Ahmed SM, Carlsson M, Tesfa Y, George M, Ali SH, Siddieg HH, Abusnana S.

Clin Nutr. 2015 Mar 24. pii: S0261-5614(15)00078-3. doi: 10.1016/j.clnu.2015.02.017. [Epub ahead of print]

PMID:
25892603
12.

Real world use of fingolimod in patients with relapsing remitting multiple sclerosis: A retrospective study utilising the national multiple sclerosis registry in Kuwait.

Al-Hashel J, Ahmed S, Behbehani R, Alroughani R.

Mult Scler Relat Disord. 2014 Nov;3(6):748. doi: 10.1016/j.msard.2014.09.175. Epub 2014 Nov 21.

PMID:
25891582
13.

The risk of short-term relapse in patients switching from natalizumab to fingolimod.

Alroughani R, Ahmed S, Al-Hashel J.

Mult Scler Relat Disord. 2014 Nov;3(6):748-9. doi: 10.1016/j.msard.2014.09.177. Epub 2014 Nov 21.

PMID:
25891580
14.

Pediatric onset multiple sclerosis patients tend to have slower disease progression.

Alroughani R, Ahmed S, Al-Hashel J.

Mult Scler Relat Disord. 2014 Nov;3(6):742-3. doi: 10.1016/j.msard.2014.09.161. Epub 2014 Nov 21.

PMID:
25891566
15.

Demographics and clinical characteristics of pediatric onset multiple sclerosis.

Alroughani R, Ahmed S, Al-Hashel J.

Mult Scler Relat Disord. 2014 Nov;3(6):739. doi: 10.1016/j.msard.2014.09.152. Epub 2014 Nov 21.

PMID:
25891557
16.

Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a Nation-Wide Cohort.

Alroughani R, Akhtar S, Ahmed S, Al-Hashel J.

Mult Scler Relat Disord. 2014 Nov;3(6):738-9. doi: 10.1016/j.msard.2014.09.151. Epub 2014 Nov 21.

PMID:
25891555
17.

Evaluation of contemporary ceramic materials.

Ahmed SN, Donovan TE, Swift EJ Jr.

J Esthet Restor Dent. 2015 Mar;27(2):59-62. doi: 10.1111/jerd.12163. No abstract available.

PMID:
25891193
18.

Construct validity of cadaveric temporal bones for training and assessment in mastoidectomy.

Awad Z, Tornari C, Ahmed S, Tolley NS.

Laryngoscope. 2015 Apr 17. doi: 10.1002/lary.25310. [Epub ahead of print]

PMID:
25891034
19.

Burden of obstetric fistula: from measurement to action.

Ahmed S, Tunçalp Ö.

Lancet Glob Health. 2015 May;3(5):e243-4. doi: 10.1016/S2214-109X(15)70105-1. No abstract available.

20.

Genotyping methods for monitoring the epidemic evolution of A. baumannii strains.

Ahmed SS, Alp E.

J Infect Dev Ctries. 2015 Apr 15;9(4):347-354. doi: 10.3855/jidc.6201. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk